BRIEF-Kalytera submits phase 2 study protocol to IRBS for cannabidiol
August 14, 2017 at 08:35 AM EDT
* Kalytera submits phase 2 study protocol to IRBS for cannabidiol in the prevention of graft versus host disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|